STE Insider Filing: Options and 487 RSUs Granted to Director Feldmann

Rhea-AI Filing Summary

In this Form 4 filing STERIS director Cynthia L. Feldmann reports a sale and new equity awards. On 08/11/2025 she sold 3,495 ordinary shares at a weighted-average price of $241.56, after which she holds 705 shares directly. The filing shows 8,663 ordinary shares held indirectly in the Cynthia L. Feldmann Revocable Trust. The report also records equity grants: on 08/08/2025 a director stock option to buy 1,407 shares at a $242.85 exercise price (exercisable immediately, expiring 08/08/2035) and 487 Career Restricted Stock Units that are fully vested and will be settled in ordinary shares six months after cessation of Board service. A director stock option with a $114.74 exercise price and 3,495 underlying shares is also listed with an exercisable date shown as 08/09/2028. The form is signed by an authorized representative on 08/12/2025.

Positive

• Equity awards granted: Director stock option for 1,407 shares at $242.85 (exercisable immediately) and 487 Career RSUs are recorded.
• Full vesting disclosed: The Career RSUs are noted as fully vested and will be settled in ordinary shares six months after cessation of Board service.

Negative

• Insider sale: The reporting person sold 3,495 ordinary shares on 08/11/2025 at a weighted-average price of $241.56.
• Reduced direct holdings: Following the sale the filing reports only 705 shares held directly by the reporting person.

Insights

Securities Analyst

TL;DR: Insider sale of 3,495 shares and concurrent option/RSU awards were reported; transactions are disclosed clearly with specific prices and dates.

The Form 4 documents a direct sale of 3,495 shares at a weighted-average $241.56 on 08/11/2025, reducing direct holdings to 705 shares. Separately, the filing records grant of a director option for 1,407 shares at $242.85 (exercisable immediately) and 487 Career RSUs that are fully vested and settle six months after board service ends. The filing provides a clear breakdown of direct and indirect holdings including 8,663 shares in a revocable trust. From a disclosure and reporting standpoint, material facts are presented precisely.

Corporate Governance Expert

TL;DR: Equity grants appear tied to director service and retention; sale reduced direct holdings while trust ownership remains significant.

The filing shows compensation-style equity activity: immediate exercisable options and fully vested Career RSUs, which typically serve retention and alignment purposes. The reporting person’s direct stake falls to 705 shares after the sale, while the Cynthia L. Feldmann Revocable Trust holds 8,663 shares indirectly, both disclosed explicitly. All transactions include dates, prices and exercisability or settlement terms where applicable, meeting customary governance disclosure expectations.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FELDMANN CYNTHIA L

(Last) (First) (Middle)

C/O 70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2 L2 D02 R296

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/11/2025		M		3,495	A	$0	4,200	D
Ordinary Shares	08/11/2025		S		3,495	D	$241.56(1)	705	D
Ordinary Shares								8,663	I	See Footnote Below(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Stock Option (right to buy)	$242.85(3)	08/08/2025		A		1,407		(3)	08/08/2035	Ordinary Shares	1,407	$0	1,407	D
Career Restricted Stock Units	(4)	08/08/2025		A		487		(5)	(5)	Ordinary Shares	487	$0	8,128	D
Director Stock Option (right to buy)	$114.74	08/11/2025		M			3,495	(3)	08/09/2028	Ordinary Shares	3,495	$0	0	D

Explanation of Responses:

1. Price reflects a weighted average sale price for multiple transactions ranging from $241.38 to $241.705 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

2. These ordinary shares are held in the Cynthia L. Feldmann Revocable Trust, with Ms. Feldmann and her husband as Trustees.

3. These nonqualified stock options are fully vested and are exercisable immediately.

4. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

5. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Cynthia Feldmann report on the Form 4 for STERIS (STE)?

The Form 4 reports a sale of 3,495 ordinary shares and the grant of director stock options and 487 Career RSUs, with full transaction details and dates.

How many shares were sold and at what price in the STE Form 4?

On 08/11/2025 Ms. Feldmann sold 3,495 shares at a weighted-average price of $241.56.

How many STERIS shares does Feldmann own after the reported transactions?

The filing shows 705 shares held directly after the sale and 8,663 ordinary shares held indirectly in the Cynthia L. Feldmann Revocable Trust.

What equity awards were granted to Feldmann according to the filing?

The filing lists a director stock option for 1,407 shares at $242.85 (exercisable immediately, expiring 08/08/2035), 487 Career RSUs (fully vested) and a director option for 3,495 shares with a $114.74 exercise price.

When will the Career Restricted Stock Units be settled?

Per the filing each Career RSU will be settled in ordinary shares six months after cessation of the Director's Board service; the RSUs are noted as fully vested immediately.